Theranostic Advances in Breast Cancer in Nuclear Medicine

The implication of 'theranostic' refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.

Automated summary

The concept of 'theranostic' involves using the same radioligand to target an identical receptor for diagnostic and therapeutic purposes. Many significant theranostic tracers have been developed in recent years, showing the direction of nuclear medicine towards therapies based on diagnosis. This review focuses on targeted radiopharmaceuticals for imaging and therapy of breast cancer.